FDA approves Pharming’s Joenja for children with APDS aged 4 to 11
AI Summary- FDA approved Pharming’s Joenja for children aged 4 to 11 with APDS.
- 40 mg and 50 mg twice-daily doses are expected to be available in October.
- Pharming submitted a separate July 30 application for lower pediatric doses.